Alector, Inc. Common Stock (ALEC)
Alector, Inc. Common Stock
XNAS:ALEC
1.35
$1.73 - 1.00
$1.28 - 568.00
$1.3
$1.35
$1.35
$1.35
3.4
0.87
569531
1377317.2
73608487.32
Chart
TendieTensor AI Analysis
Company
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Fundamentals
163
-1.240000
2.476120
-0.34
100
BBG00N0PL198
BBG00N0PL214
101.21M
109.15M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ALEC. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.